Welcome to Markets Desk, here's what's moving the needle today.
Pfizer and Blackstone Life Sciences are joining forces on a deal worth up to one point five billion dollars to co-fund development of Berobenatide, Pfizer's obesity drug candidate. Blackstone commits the capital through two thousand twenty eight, giving Pfizer a meaningful runway without shouldering the full development burden alone — a structure that signals growing private appetite for late-stage pharma risk.
Shifting to crypto regulation, South Korea is moving to authorize exchanges to freeze withdrawal activity during active hacking threats. The policy follows a precautionary suspension at GOPAX and a breach at Prabang that cost roughly seventy thousand dollars from a hot wallet. It's a notable step toward codifying real-time security powers for Korean platforms, which have faced persistent vulnerability concerns.
And on Robinhood, analysts are mapping out where the platform stands in three years as it leans harder into diversification. The core thesis is straightforward — as user needs mature beyond commission-free equities, Robinhood's expansion into retirement accounts, credit, and prediction markets positions it to capture wallet share rather than lose it to incumbents.
That's the tape. Markets Desk, signing off the floor.
